Dr. Richard Isaacson’s latest research was featured on CNN’s The Lead with Jake Tapper, where Chief Medical Correspondent Dr. Sanjay Gupta discussed a groundbreaking study demonstrating how blood biomarkers can be used not only to assess Alzheimer’s risk but also to monitor how lifestyle interventions may improve brain health over time.

During the segment, Dr. Gupta highlighted Dr. Isaacson’s personalized prevention approach, explaining how biomarker testing can help guide targeted recommendations based on an individual’s unique risk profile. He also shared practical strategies from the study—including weighted walking, continuous glucose monitoring, reducing inflammation, and using toe spacers to support balance and proprioception—crediting Dr. Isaacson for emphasizing how these interventions may contribute to long-term cognitive health.

Watch the full segment on CNN’s The Lead with Jake Tapper to learn how precision medicine and blood biomarker testing are helping reshape the future of Alzheimer’s prevention.